The Recall Desk
HighFDA (Devices)·Z-1132-2018·Announced 2018-03-28

NxStage PureFlow B Solution Recalled for Missing Labeling Warnings

NxStage Medical is recalling 1,243,400 units of PureFlow B Solution because the original labeling failed to warn against mixing dialysate formulations.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II and involves a risk of harm to patients due to missing safety warnings, but the source text does not report specific injuries or illnesses, fitting the 'High' severity criteria for risk-of-harm products where injury has not yet been reported.

Plain-English summary

NxStage Medical, Inc. is recalling 1,243,400 units of NxStage PureFlow B Solution - Premixed Dialysate for Hemodialysis with NxStage System One. The product was distributed nationwide in the United States.

The recall was initiated because the original labeling did not warn against using different fluid formulations of the solution at the same time during treatment. Additionally, the labeling did not instruct staff to verify that the fluid is flowing during use. Using different formulations simultaneously may cause patient health risk.

Healthcare facilities and users should stop using the affected units and contact NxStage Medical for further instructions. The affected product codes are listed in the official recall documentation.

The recalled product

Product
NxStage PureFlow B Solution - Premixed Dialysate for Hemodialysis with NxStage System One
Affected units
1,243,400

Distribution

Distributed nationwide across the United States.